TD Asset Management
BOLD

TD Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

TD Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,982
Closed -$421K – 1436
2019
Q3 		$421K Sell
14,982
-8,140
-35% -$278K ﹤0.01% 1201
2019
Q2 		$875K Sell
23,122
-5,300
-19% -$204K ﹤0.01% 1074
2019
Q1 		$1.11M Sell
28,422
-300
-1% -$8.6K ﹤0.01% 1019
2018
Q4 		$612K Sell
28,722
-33,300
-54% -$859K ﹤0.01% 1179
2018
Q3 		$2.46M Buy
62,022
+2,800
+5% +$104K ﹤0.01% 939
2018
Q2 		$2.26M Buy
59,222
+9,600
+19% +$356K ﹤0.01% 927
2018
Q1 		$1.49M Buy
49,622
+2,932
+6% +$99.3K ﹤0.01% 961
2017
Q4 		$1.46M Buy
46,690
+21,510
+85% +$591K ﹤0.01% 957
2017
Q3 		$705K Sell
25,180
-100
-0.4% -$2.17K ﹤0.01% 1115
2017
Q2 		$484K Buy
25,280
+598
+2% +$9.55K ﹤0.01% 1189
2017
Q1 		$421K Buy
24,682
+14,082
+133% +$228K ﹤0.01% 1250
2016
Q4 		$194K Sell
10,600
-100
-0.9% -$1.73K ﹤0.01% 1345
2016
Q3 		$191K Buy
+10,700
New +$162K ﹤0.01% 1372

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

TD Asset Management's BOLD Position: Q4 2019 in Review

TD Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 14,982 shares — an estimated $421K sold.

TD Asset Management first reported a position in BOLD in Q3 2016 and held it in 13 quarters. The position peaked at $2.46M in Q3 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • TD Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • TD Asset Management sold 14,982 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $421K.
  • TD Asset Management first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 13 quarters.
  • TD Asset Management's Audentes Therapeutics, Inc position peaked at $2.46M in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on TD Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.